Deanxit and Rivotril in Tinnitus Patients

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate whether increased tinnitus reduction can be obtained with Deanxit in patients already receiving Rivotril.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Antwerp
• Treatments: Clonazepam

Criteria

Inclusion Criteria:

• pure tone, narrow band noise or polyphonic tinnitus

• unilateral or bilateral tinnitus

• VAS ≥ 4

• cochleair origin tinnitus

• tinnitus present 3 months or more

• age 18y or more

• intake Rivotril 1mg/d

• patient 'able to cooperate'

• patient able to fill in TQ en VAS

• No pontine angle pathology on MRI

Exclusion Criteria:

• pulsatile tinnitus

• pregnancy or breast feeding

• contra-indications Deanxit

• recovery myocard infarct

• conduction disorder His

• untreated glaucoma

• MAO inhibitors: 15d stop

• otosclerosis

• middle ear pathologies

• Ménière

• somatic tinnitus